From Medscape Oncology

Medscape Coverage from the

National Comprehensive Cancer Network (NCCN) 22nd Annual Conference

March 23 - 25, 2017; Orlando, Florida

March 23 - 25, 2017 Orlando, Florida

NCCN A New Trend in Pancreatic Cancer Treatment Neoadjuvant chemotherapy is now being used in various centers for select patients. And clinical trials are pushing the presurgery chemo envelope in patients who are 'borderline' candidates for surgery. Here's why.
Medscape Medical News, March 30, 2017
NCCN New US Cancer Staging System Debuts in 9 Months The American Joint Committee on Cancer has a new staging system that elevates 'prognostic' status as the official staging classification of every cancer in the United States.
Medscape Medical News, March 28, 2017
NCCN NCCN Updates Lung Cancer Guideline, Again Change and more change is happening in lung cancer, and the National Comprehensive Cancer Network (NCCN) is keeping pace in its guidelines.
Medscape Medical News, March 24, 2017

Conference News

NCCN Six Insights: Clinicians Help Cancer Patients Quit Smoking
Medscape Medical News, March 30, 2017
NCCN A New Trend in Pancreatic Cancer Treatment
Medscape Medical News, March 30, 2017
NCCN New US Cancer Staging System Debuts in 9 Months
Medscape Medical News, March 28, 2017

NCCN A Married Couple Walk Into an Oncologist's Office...
Medscape Medical News, March 27, 2017
NCCN NCCN Updates Lung Cancer Guideline, Again
Medscape Medical News, March 24, 2017

Most Popular News from NCCN 21st Conference

NCCN Takes New Look at Vulvar Cancer Vulvar cancer is rare. Even oncologists who specialize in gynecologic cancers might only see one or two cases a year, so randomized trials are difficult to conduct.
Medscape Medical News, Apr 6, 2016
NCCN Scrutinizes Sexual Dysfunction in Cancer Survivors The National Comprehensive Cancer Network (NCCN) Guidelines for Survivorship focus this year on issues of sexual health for both men and women.
Medscape Medical News, Apr 7, 2016
New Genetic Mutations for Hereditary Women's Cancers NCCN has added new genetic mutations to be considered when determining risk-management strategies for hereditary breast and ovarian cancers.
Medscape Medical News, Apr 4, 2016

Medscape Oncology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage